Sa. Spinler et al., Predictive performance study of two digoxin assays in subjects with various degrees of renal function, THER DRUG M, 22(6), 2000, pp. 729-736
This prospective study was conducted to compare the predictive performance
of fluorescence polarization immunoassay (FPIA, Abbott TDx Digoxin II) and
radioimmunoassay (RTA, Kallestad Labs) with combined low-pressure liquid ch
romatography/RIA (LPLC/RIA) digoxin assay in measuring 15-17 serum digoxin
concentrations (SDC) obtained after a single 10 mug/kg intravenous digoxin
dose in patients with various degrees of renal function and at different SD
C ranges. Eighteen men and women were stratified into 3 age- and gender-mat
ched groups based upon renal function [N = 6 in each, group I(Cl-cr < 10 mL
/min), group II (Cl-cr = 10-50 mL/min), and group III (Cl-cr > 50 mL/min)].
Serum digoxin concentrations were measured at time zero; at 0.25, 0.5, 0.7
5, 1, 2, 3, 4, 6, 8, and 12 hours; and at 2, 3, 4, and 5-7 days after the d
igoxin dose, using the three different digoxin assays. TDx Digoxin II was u
nbiased [mean error -0.09 (95% CI -0.19, 0.01)] and RIA biased [mean error
-0.29 (95% CI -0.36, -0.21)] to over-predict SDC by 14.2%. In group I patie
nts, the analysis revealed a bias to over-predict SDC by 6.0% for TDx Digox
in II [ mean error -0.16 (95% CI -0.29, -0.07)] and an unbiased performance
by RIA. In groups IT and III, both TDx Digoxin II and RIA showed biased pe
rformance, the mean magnitude of bias was low (< 20%). For intermediate SDC
range (> 0.5 ng/mL and less than or equal to 3.0 ng/mL), TDx Digoxin II wa
s unbiased in predicting SDC, whereas RIA was biased to under-predict SDC [
mean error 0.13 (95% CI 0.10, 0.16)] by 9.9%. The magnitude of bias observe
d in all cases was less than 20%. Both assays, TDx Digoxin II and RIA, impr
ecisely measured SDC for all samples combined, different groups and SDC ran
ges. In all time-paired samples, TDx Digoxin II (FPIA) performed better tha
n the RIA. In conclusion, the magnitude of bias observed with either assay
at different groups and SDC ranges was not likely to be clinically relevant
. Therefore, either assay may be used to measure SDC in clinical practice.